- Published on
Infectious Disease - Exanthem Subitum (Roseola Infantum)
Exanthema subitum is a benign, self-limiting viral infection in children, primarily caused by human herpesvirus 6B (HHV-6B) or, less commonly, by human herpesvirus 7 (HHV-7).
It is sometimes referred to as roseola infantum or sixth sickness.
EPIDEMIOLOGY
Incidence
• It is global.
• Infections predominantly arise between 6 months and 3 years, with 90% occurring prior to the age of 2 years.
Human herpesvirus 7 induces sickness in older children and may correlate with an increased prevalence of febrile seizures.
• Antibody prevalence in the US population over the age of 3 years reaches 100%.
• Antibody titers in the infant, derived from maternal antibodies, are elevated initially, decrease until six months of age, and thereafter increase once more. • Antibody concentrations may remain elevated until the age of 60 years.
Frequency
Human herpesvirus 6B accounts for roughly 10–45% of all febrile illnesses in pediatric patients.
RISK FACTORS
Genetics
In the United States, 1% of individuals are born with hereditary chromosomally integrated HHV-6 infection, originally identified in 1993, with its clinical implications remaining unknown to date.
GENERAL PREVENTION • At present, there is no method to avert initial infection or reactivation of human herpesvirus 6.
Prophylaxis may be required for patients receiving bone marrow transplantation.
PATHOPHYSIOLOGY • The virus remains in a latent condition within secondary lymphoid tissues.
Organs , saliva, and the CNS exhibit a distinct mode of infection following original exposure, unlike other human herpesviruses.
• It can be located in activated CD4+ T-lymphocytes, monocytes, macrophages, endothelial cells, epithelial cells, astrocytes, and B cells, in addition to many organs throughout the body.
Reactivation of the illness predominantly occurs in immunocompromised individuals.
ETIOLOGY • Human herpesvirus 6 exhibits significant genetic similarity to cytomegalovirus (CMV), with a homology of 50%, both belonging to the Beta 2 herpesvirus group.
Human herpesvirus 6A and 6B should be regarded as distinct viruses due to their significant differences.
• The existence of human herpesvirus 7.
FREQUENTLY ASSOCIATED CONDITIONS
This virus may be linked to transplantation.
The association of this virus with several disorders, including AIDS, lymphoma, leukemia, chronic fatigue syndrome, drug-induced hypersensitivity syndrome, and multiple sclerosis in adults, is currently under examination.
HISTORICAL DIAGNOSIS
The incubation phase lasts 10 to 14 days.
Pediatric Patients
• It is a non-threatening condition in children characterized by upper respiratory symptoms, fever, and rash.
• This sickness has been linked to fevers exceeding 41°C.
The child is generally in a mild state of illness, except from the elevated fever.
A maculopapular rash commonly manifests in 10% of cases following the febrile episode, however instances of the disease without a rash are more prevalent. A rash may appear without accompanying fever.
• Upper respiratory symptoms affecting the pharynx, tonsils, and ears, absent conjunctivitis and pharyngeal exudates.
Cervical lymphadenopathy is frequently observed.
• The duration of the illness is 3 to 5 days.
Gastrointestinal symptoms, such as diarrhea and vomiting, may manifest.
• Febrile seizures occur in 10% of cases.
• It is an uncommon etiology of encephalitis in non-transplant patients Grown individuals
• Illness resembling mononucleosis. • This may result in upper respiratory infections or pneumonia accompanied by hepatitis.
Organ Transplant Recipients
Exanthem subitum should be regarded as a potential diagnosis in organ transplant recipients.
Human herpesvirus 6 is a significant contributor to bone marrow suppression and interstitial pneumonitis following bone marrow transplantation.
PHYSICAL EXAMINATION • Fever: Reaching 41°C with sudden onset and rapid resolution.
Rash: Macular or maculopapular, pink, transitory, nonpruritic, devoid of pigmentation and desquamation, emerges when fever abates, initially on the trunk, thereafter disseminating to the face, neck, and limbs, resolving within 1–2 days.
Cervical lymphadenopathy.
• Overall satisfactory condition of the patient.
The anterior fontanelle in neonates may exhibit bulging.
DIAGNOSTIC TESTS AND INTERPRETATION
Laboratory
• Leukopenia • Mononucleosis • Lymphocytopenia • Atypical lymphocytes • Hepatitis, particularly in adults
• The erythrocyte sedimentation rate is within normal limits. • The cerebrospinal fluid is within normal parameters.
Diagnosis is accomplished using viral isolation, PCR, and serological methods.
• Viral isolation using fast antigen detection from a specimen or tissue culture.
• Serological analysis: IgG and IgM antibodies, antibody avidity, ELISA assay
The existing serological assays are unable to differentiate between HHV-6A and HHV-6B.
• Detection using PCR or real-time PCR in cells or plasma The rapid shell vial assay is employed for transplant recipients.
Magnetic resonance imaging is indicated in cases of suspected central nervous system involvement.
Differential Diagnosis
• Cytomegalovirus (CMV) • Viral upper respiratory infection • Adenovirus • Hepatitis A, B, and C • Measles, rubella
• Significant bacterial infections: The child's health, despite the fever, the rash following the febrile episode, a normal erythrocyte sedimentation rate, and normal CSF fluid support the diagnosis of exanthema subitum. In instances of antibiotic administration, the rash may be regarded as a drug allergy.
THERAPEUTIC MEDICATION • There is no definitive treatment; in the majority of instances, the approach is supportive care.
The condition is responsive to ganciclovir or foscarnet; however, treatment is typically restricted to those who are unwell post-bone marrow transplantation or in severe instances.
SUPPLEMENTARY THERAPY
Comprehensive Strategies
• Medical care is typically provided on an outpatient basis. Instances of febrile seizures or central nervous system involvement necessitate hospitalization.
Utilize acetaminophen/paracetamol and baths to manage fever. • Maintain sufficient hydrated.
ONGOING CARE PROGNOSIS
It is non-threatening and self-resolving, typically associated with a favorable prognosis.
COMPLICATIONS
• Primarily manifest in immunocompromised individuals: Pneumonia
• Hepatitis • Bone marrow suppression
• Encephalitis, meningoencephalitis, and aseptic meningitis
Exanthema subitum is a benign, self-limiting viral infection in children, primarily caused by human herpesvirus 6B (HHV-6B) or, less commonly, by human herpesvirus 7 (HHV-7).
It is sometimes referred to as roseola infantum or sixth sickness.
EPIDEMIOLOGY
Incidence
• It is global.
• Infections predominantly arise between 6 months and 3 years, with 90% occurring prior to the age of 2 years.
Human herpesvirus 7 induces sickness in older children and may correlate with an increased prevalence of febrile seizures.
• Antibody prevalence in the US population over the age of 3 years reaches 100%.
• Antibody titers in the infant, derived from maternal antibodies, are elevated initially, decrease until six months of age, and thereafter increase once more. • Antibody concentrations may remain elevated until the age of 60 years.
Frequency
Human herpesvirus 6B accounts for roughly 10–45% of all febrile illnesses in pediatric patients.
RISK FACTORS
Genetics
In the United States, 1% of individuals are born with hereditary chromosomally integrated HHV-6 infection, originally identified in 1993, with its clinical implications remaining unknown to date.
GENERAL PREVENTION • At present, there is no method to avert initial infection or reactivation of human herpesvirus 6.
Prophylaxis may be required for patients receiving bone marrow transplantation.
PATHOPHYSIOLOGY • The virus remains in a latent condition within secondary lymphoid tissues.
Organs , saliva, and the CNS exhibit a distinct mode of infection following original exposure, unlike other human herpesviruses.
• It can be located in activated CD4+ T-lymphocytes, monocytes, macrophages, endothelial cells, epithelial cells, astrocytes, and B cells, in addition to many organs throughout the body.
Reactivation of the illness predominantly occurs in immunocompromised individuals.
ETIOLOGY • Human herpesvirus 6 exhibits significant genetic similarity to cytomegalovirus (CMV), with a homology of 50%, both belonging to the Beta 2 herpesvirus group.
Human herpesvirus 6A and 6B should be regarded as distinct viruses due to their significant differences.
• The existence of human herpesvirus 7.
FREQUENTLY ASSOCIATED CONDITIONS
This virus may be linked to transplantation.
The association of this virus with several disorders, including AIDS, lymphoma, leukemia, chronic fatigue syndrome, drug-induced hypersensitivity syndrome, and multiple sclerosis in adults, is currently under examination.
HISTORICAL DIAGNOSIS
The incubation phase lasts 10 to 14 days.
Pediatric Patients
• It is a non-threatening condition in children characterized by upper respiratory symptoms, fever, and rash.
• This sickness has been linked to fevers exceeding 41°C.
The child is generally in a mild state of illness, except from the elevated fever.
A maculopapular rash commonly manifests in 10% of cases following the febrile episode, however instances of the disease without a rash are more prevalent. A rash may appear without accompanying fever.
• Upper respiratory symptoms affecting the pharynx, tonsils, and ears, absent conjunctivitis and pharyngeal exudates.
Cervical lymphadenopathy is frequently observed.
• The duration of the illness is 3 to 5 days.
Gastrointestinal symptoms, such as diarrhea and vomiting, may manifest.
• Febrile seizures occur in 10% of cases.
• It is an uncommon etiology of encephalitis in non-transplant patients Grown individuals
• Illness resembling mononucleosis. • This may result in upper respiratory infections or pneumonia accompanied by hepatitis.
Organ Transplant Recipients
Exanthem subitum should be regarded as a potential diagnosis in organ transplant recipients.
Human herpesvirus 6 is a significant contributor to bone marrow suppression and interstitial pneumonitis following bone marrow transplantation.
PHYSICAL EXAMINATION • Fever: Reaching 41°C with sudden onset and rapid resolution.
Rash: Macular or maculopapular, pink, transitory, nonpruritic, devoid of pigmentation and desquamation, emerges when fever abates, initially on the trunk, thereafter disseminating to the face, neck, and limbs, resolving within 1–2 days.
Cervical lymphadenopathy.
• Overall satisfactory condition of the patient.
The anterior fontanelle in neonates may exhibit bulging.
DIAGNOSTIC TESTS AND INTERPRETATION
Laboratory
• Leukopenia • Mononucleosis • Lymphocytopenia • Atypical lymphocytes • Hepatitis, particularly in adults
• The erythrocyte sedimentation rate is within normal limits. • The cerebrospinal fluid is within normal parameters.
Diagnosis is accomplished using viral isolation, PCR, and serological methods.
• Viral isolation using fast antigen detection from a specimen or tissue culture.
• Serological analysis: IgG and IgM antibodies, antibody avidity, ELISA assay
The existing serological assays are unable to differentiate between HHV-6A and HHV-6B.
• Detection using PCR or real-time PCR in cells or plasma The rapid shell vial assay is employed for transplant recipients.
Magnetic resonance imaging is indicated in cases of suspected central nervous system involvement.
Differential Diagnosis
• Cytomegalovirus (CMV) • Viral upper respiratory infection • Adenovirus • Hepatitis A, B, and C • Measles, rubella
• Significant bacterial infections: The child's health, despite the fever, the rash following the febrile episode, a normal erythrocyte sedimentation rate, and normal CSF fluid support the diagnosis of exanthema subitum. In instances of antibiotic administration, the rash may be regarded as a drug allergy.
THERAPEUTIC MEDICATION • There is no definitive treatment; in the majority of instances, the approach is supportive care.
The condition is responsive to ganciclovir or foscarnet; however, treatment is typically restricted to those who are unwell post-bone marrow transplantation or in severe instances.
SUPPLEMENTARY THERAPY
Comprehensive Strategies
• Medical care is typically provided on an outpatient basis. Instances of febrile seizures or central nervous system involvement necessitate hospitalization.
Utilize acetaminophen/paracetamol and baths to manage fever. • Maintain sufficient hydrated.
ONGOING CARE PROGNOSIS
It is non-threatening and self-resolving, typically associated with a favorable prognosis.
COMPLICATIONS
• Primarily manifest in immunocompromised individuals: Pneumonia
• Hepatitis • Bone marrow suppression
• Encephalitis, meningoencephalitis, and aseptic meningitis
0 Comments
